The present invention is directed to compounds that are inhibitors of cysteine protease, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
本发明涉及一种抑制半胱
氨酸
蛋白酶的化合物,特别是cathepsin B、K、L、F和S,因此可用于治疗由这些
蛋白酶介导的疾病。本发明涉及包含这些化合物的制药组合物和制备它们的过程。